Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy

Details for Australian Patent Application No. 2011224410 (hide)

Owner The Broad Institute, Inc. Dana-Farber Cancer Institute, Inc.

Inventors Garraway, Levi A.; Johannessen, Cory M.

Agent Spruson & Ferguson

Pub. Number AU-A-2011224410

PCT Pub. Number WO2011/112678

Priority 61/415,569 19.11.10 US; 61/312,193 09.03.10 US; 61/326,021 20.04.10 US; 61/312,519 10.03.10 US

Filing date 9 March 2011

Wipo publication date 15 September 2011

International Classifications

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 31/4184

C12N 9/12 Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/112678 Priority application(s): WO2011/112678

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011224411-Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same

2011224409-Heavy-duty axle/suspension system